🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Very few patients with endocrine-resistant, hormone-receptor positive metas...
Status
Recruiting
Location
Shaare Zedek Medical Center
Start Date
2019-04-18
Trial ID
NCT03591276
Treatments Being Tested
Phase 1a/1b does-escalation study of cabiralizumab alone and with nivolumab...
Status
Completed
Location
Scottsdale Healthcare Hospitals DBA Honor Health
Start Date
2015-09-08
Trial ID
NCT02526017
Treatments Being Tested
Phase Ib/II open label, multicenter study to evaluate the efficacy and safe...
Status
Active Not Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2022-05-04
Trial ID
NCT05229497
Treatments Being Tested
This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06665087
This is an open-label, single-arm, single-cohort, prospective clinical stud...
Status
Not Yet Recruiting
Location
Departmeng of Urology, Peking University First Hospita
Start Date
2026-08-01
Trial ID
NCT07720921
Treatments Being Tested
This study is designed to evaluate the safety and tolerability of treatment...
Status
Completed
Location
The Angeles Clinic and Research Institute
Start Date
2019-01-28
Trial ID
NCT03817125
Treatments Being Tested
This is a Phase 1, open-label, dose escalation study in patients with advan...
Status
Completed
Location
Next Oncology
Start Date
2020-09-23
Trial ID
NCT04501276
Treatments Being Tested
This study will look at the efficacy and safety of QL1706 plus albumin-boun...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-06
Trial ID
NCT06404463
The prognosis of patients with "high-grade B cell lymphoma with cellular my...
Status
Active Not Recruiting
Location
BE-Antwerpen-ZNASTUIVENBERG
Start Date
2018-08-01
Trial ID
NCT03620578
Treatments Being Tested
This is a multicenter, randomized, open-label, phase III clinical study, to...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-09-10
Trial ID
NCT07174908